Intellia Therapeutics, Inc.
US ˙ NasdaqGM ˙ US45826J1051

SecurityNTLA / Intellia Therapeutics, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership21,438 shares
Latest Disclosed Value $ 362,731
Wolverine Trading, Llc ownership in NTLA / Intellia Therapeutics, Inc.

On November 14, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 21,438 shares of Intellia Therapeutics, Inc. (US:NTLA) valued at $370,234 USD as of September 30, 2025. The entity filed a previous 13F-HR on May 15, 2025 disclosing 0 shares of Intellia Therapeutics, Inc.. The current value of the position is $279,123 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (NTLA) in the form of stock options. The firm currently holds call options representing 163,100 of underlying shares valued at $2,759,652 USD and put options representing 66,400 of underlying shares valued at $1,123,488 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NTLA / Intellia Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 21,438 21,438 363 0.0003
2025-05-15 2025-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 0 -31,015 -100.00 0 -100.00
2025-02-14 2024-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 31,015 20,314 189.83 354 57.59 0.0003
2024-11-14 2024-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 10,701 -768 -6.70 225 -12.50 0.0002
2024-08-14 2024-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 11,469 571 5.24 257 -14.38 0.0003
2024-05-15 2024-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 10,898 -913 -7.73 300 -16.94 0.0003
2024-02-14 2023-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 11,811 1,028 9.53 360 5.88 0.0004
2023-11-15 2023-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 10,783 4,315 66.71 341 28.79 0.0004
2023-08-23 2023-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 6,468 6,468 265 0.0003
2023-05-15 2023-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 0 -7,964 -100.00 0 -100.00
2023-02-14 2022-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 7,964 3,719 87.61 278 18.30 0.0004
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 4,245 -231 -5.16 235 0.00 0.0004
2022-08-15 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 4,476 -719 -13.84 235 -37.33 0.0004
2022-05-16 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 5,195 -362 -6.51 375 -44.36 0.0005
2022-02-14 2021-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 5,557 -992 -15.15 674 -25.19 0.0008
2021-11-12 2021-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 6,549 4,277 188.25 901 161.92 0.0010
2021-08-06 2021-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 2,272 -6,100 -72.86 344 -43.14 0.0005
2021-05-14 2021-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 8,372 8,372 605 0.0009
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F INTELLIA THERAPEUTICS COM Call 163,100 2,760 n/a n/a n/a
2025-08-18 2025-06-30 13F INTELLIA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F INTELLIA THERAPEUTICS COM Call 102,200 59.69 825 12.88 n/a n/a n/a
2025-02-14 2024-12-31 13F INTELLIA THERAPEUTICS COM Call 64,000 64.52 730 -10.54 n/a n/a n/a
2024-11-14 2024-09-30 13F INTELLIA THERAPEUTICS COM Call 38,900 -17.23 817 -22.36 n/a n/a n/a
2024-08-14 2024-06-30 13F INTELLIA THERAPEUTICS COM Call 47,000 88.76 1,052 53.65 n/a n/a n/a
2024-05-15 2024-03-31 13F INTELLIA THERAPEUTICS COM Call 24,900 -1.97 685 -11.63 n/a n/a n/a
2024-02-14 2023-12-31 13F INTELLIA THERAPEUTICS COM Call 25,400 -5.22 774 -8.62 n/a n/a n/a
2023-11-15 2023-09-30 13F INTELLIA THERAPEUTICS COM Call 26,800 57.65 847 21.87 n/a n/a n/a
2023-08-23 2023-06-30 13F INTELLIA THERAPEUTICS COM Call 17,000 -2.86 695 n/a n/a n/a
2023-05-15 2023-03-31 13F INTELLIA THERAPEUTICS COM Call 17,500 -7.89 1 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F INTELLIA THERAPEUTICS COM Call 19,000 3.83 663 -34.49 n/a n/a n/a
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM Call 18,300 3.98 1,012 9.64 n/a n/a n/a
2022-08-15 2022-06-30 13F INTELLIA THERAPEUTICS COM Call 17,600 29.41 923 -6.01 n/a n/a n/a
2022-05-16 2022-03-31 13F INTELLIA THERAPEUTICS COM Call 13,600 24.77 982 -25.72 n/a n/a n/a
2022-02-14 2021-12-31 13F INTELLIA THERAPEUTICS COM Call 10,900 -14.84 1,322 -24.93 n/a n/a n/a
2021-11-12 2021-09-30 13F INTELLIA THERAPEUTICS COM Call 12,800 -53.96 1,761 -58.22 n/a n/a n/a
2021-08-06 2021-06-30 13F INTELLIA THERAPEUTICS COM Call 27,800 37.62 4,215 188.90 n/a n/a n/a
2021-05-14 2021-03-31 13F INTELLIA THERAPEUTICS COM Call 20,200 1,459 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F INTELLIA THERAPEUTICS COM Put 66,400 1,123 n/a n/a n/a
2025-08-18 2025-06-30 13F INTELLIA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F INTELLIA THERAPEUTICS COM Put 23,700 -10.90 191 -36.96 n/a n/a n/a
2025-02-14 2024-12-31 13F INTELLIA THERAPEUTICS COM Put 26,600 -8.90 304 -50.57 n/a n/a n/a
2024-11-14 2024-09-30 13F INTELLIA THERAPEUTICS COM Put 29,200 27.51 613 19.73 n/a n/a n/a
2024-08-14 2024-06-30 13F INTELLIA THERAPEUTICS COM Put 22,900 8.02 513 -12.18 n/a n/a n/a
2024-05-15 2024-03-31 13F INTELLIA THERAPEUTICS COM Put 21,200 2.91 583 -7.17 n/a n/a n/a
2024-02-14 2023-12-31 13F INTELLIA THERAPEUTICS COM Put 20,600 -14.17 628 -17.15 n/a n/a n/a
2023-11-15 2023-09-30 13F INTELLIA THERAPEUTICS COM Put 24,000 -9.43 759 -30.01 n/a n/a n/a
2023-08-23 2023-06-30 13F INTELLIA THERAPEUTICS COM Put 26,500 9.05 1,084 n/a n/a n/a
2023-05-15 2023-03-31 13F INTELLIA THERAPEUTICS COM Put 24,300 -37.53 1 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F INTELLIA THERAPEUTICS COM Put 38,900 -8.04 1,357 -41.98 n/a n/a n/a
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM Put 42,300 5.22 2,339 10.96 n/a n/a n/a
2022-08-15 2022-06-30 13F INTELLIA THERAPEUTICS COM Put 40,200 346.67 2,108 224.31 n/a n/a n/a
2022-05-16 2022-03-31 13F INTELLIA THERAPEUTICS COM Put 9,000 30.43 650 -22.34 n/a n/a n/a
2022-02-14 2021-12-31 13F INTELLIA THERAPEUTICS COM Put 6,900 -58.68 837 -63.56 n/a n/a n/a
2021-11-12 2021-09-30 13F INTELLIA THERAPEUTICS COM Put 16,700 -20.48 2,297 -27.86 n/a n/a n/a
2021-08-06 2021-06-30 13F INTELLIA THERAPEUTICS COM Put 21,000 35.48 3,184 184.29 n/a n/a n/a
2021-05-14 2021-03-31 13F INTELLIA THERAPEUTICS COM Put 15,500 1,120 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.